Xiaoyan Ma - Search Results

Year	Number of Results
2003	2
2004	1
2005	2
2006	4
2007	5
2008	8
2009	15
2010	11
2011	14
2012	20
2013	24
2014	14
2015	25
2016	25
2017	26
2018	25
2019	33
2020	47
2021	68
2022	85
2023	73
2024	75
2025	57

1

Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy.

Shi Y, Tao M, Ma X, Hu Y, Huang G, Qiu A, Zhuang S, Liu N. Shi Y, et al. Among authors: ma x. Cell Death Dis. 2020 Jun 17;11(6):467. doi: 10.1038/s41419-020-2673-z. Cell Death Dis. 2020. PMID: 32555189 Free PMC article.

2

SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1.

Deng L, Liao L, Zhang YL, Yang SY, Hu SY, Andriani L, Ling YX, Ma XY, Zhang FL, Shao ZM, Li DQ. Deng L, et al. Sci Adv. 2024 Apr 5;10(14):eadj4009. doi: 10.1126/sciadv.adj4009. Epub 2024 Apr 3. Sci Adv. 2024. PMID: 38569025 Free PMC article.

3

Generation and testing of clinical-grade exosomes for pancreatic cancer.

Mendt M, Kamerkar S, Sugimoto H, McAndrews KM, Wu CC, Gagea M, Yang S, Blanko EVR, Peng Q, Ma X, Marszalek JR, Maitra A, Yee C, Rezvani K, Shpall E, LeBleu VS, Kalluri R. Mendt M, et al. Among authors: ma x. JCI Insight. 2018 Apr 19;3(8):e99263. doi: 10.1172/jci.insight.99263. eCollection 2018 Apr 19. JCI Insight. 2018. PMID: 29669940 Free PMC article.

4

Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer.

Liao L, Zhang YL, Deng L, Chen C, Ma XY, Andriani L, Yang SY, Hu SY, Zhang FL, Shao ZM, Li DQ. Liao L, et al. Cancer Res. 2023 Feb 3;83(3):471-484. doi: 10.1158/0008-5472.CAN-22-2709. Cancer Res. 2023. PMID: 36484700 Free PMC article.

5

HOTTIP-dependent R-loop formation regulates CTCF boundary activity and TAD integrity in leukemia.

Luo H, Zhu G, Eshelman MA, Fung TK, Lai Q, Wang F, Zeisig BB, Lesperance J, Ma X, Chen S, Cesari N, Cogle C, Chen B, Xu B, Yang FC, So CWE, Qiu Y, Xu M, Huang S. Luo H, et al. Among authors: ma x. Mol Cell. 2022 Feb 17;82(4):833-851.e11. doi: 10.1016/j.molcel.2022.01.014. Mol Cell. 2022. PMID: 35180428 Free PMC article.

6

In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer.

Ji P, Gong Y, Jin ML, Wu HL, Guo LW, Pei YC, Chai WJ, Jiang YZ, Liu Y, Ma XY, Di GH, Hu X, Shao ZM. Ji P, et al. Sci Adv. 2022 Jul;8(26):eabl8247. doi: 10.1126/sciadv.abl8247. Epub 2022 Jun 29. Sci Adv. 2022. PMID: 35767614 Free PMC article.

7

Blockade of Autophagy Prevents the Progression of Hyperuricemic Nephropathy Through Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis.

Hu Y, Shi Y, Chen H, Tao M, Zhou X, Li J, Ma X, Wang Y, Liu N. Hu Y, et al. Among authors: ma x. Front Immunol. 2022 Mar 2;13:858494. doi: 10.3389/fimmu.2022.858494. eCollection 2022. Front Immunol. 2022. PMID: 35309342 Free PMC article.

8

Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state.

Echeverria GV, Ge Z, Seth S, Zhang X, Jeter-Jones S, Zhou X, Cai S, Tu Y, McCoy A, Peoples M, Sun Y, Qiu H, Chang Q, Bristow C, Carugo A, Shao J, Ma X, Harris A, Mundi P, Lau R, Ramamoorthy V, Wu Y, Alvarez MJ, Califano A, Moulder SL, Symmans WF, Marszalek JR, Heffernan TP, Chang JT, Piwnica-Worms H. Echeverria GV, et al. Among authors: ma x. Sci Transl Med. 2019 Apr 17;11(488):eaav0936. doi: 10.1126/scitranslmed.aav0936. Sci Transl Med. 2019. PMID: 30996079 Free PMC article.

9

CCL19⁺ dendritic cells potentiate clinical benefit of anti-PD-(L)1 immunotherapy in triple-negative breast cancer.

Wu SY, Zhang SW, Ma D, Xiao Y, Liu Y, Chen L, Song XQ, Ma XY, Xu Y, Chai WJ, Jin X, Shao ZM, Jiang YZ. Wu SY, et al. Med. 2023 Jun 9;4(6):373-393.e8. doi: 10.1016/j.medj.2023.04.008. Epub 2023 May 17. Med. 2023. PMID: 37201522 Free article.

10

Ubiquitin-specific protease 11 promotes partial epithelial-to-mesenchymal transition by deubiquitinating the epidermal growth factor receptor during kidney fibrosis.

Shi Y, Tao M, Chen H, Ma X, Wang Y, Hu Y, Zhou X, Li J, Cui B, Qiu A, Zhuang S, Liu N. Shi Y, et al. Among authors: ma x. Kidney Int. 2023 Mar;103(3):544-564. doi: 10.1016/j.kint.2022.11.027. Epub 2022 Dec 26. Kidney Int. 2023. PMID: 36581018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

592 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

592 results

Results by year